Adjuvant High‐Dose Interferon‐α for Resected Melanoma in a Patient with HIV Infection
نویسندگان
چکیده
منابع مشابه
Adjuvant treatment for patients with surgically resected advanced-stage melanoma.
KG The first step is to determine the risk of relapse and death for individual patients. Presently, the factors that guide our risk prediction are the presence or absence of a positive sentinel lymph node, the thickness of the tumor, the mitotic rate, and the presence or absence of ulceration. The current American Joint Committee on Cancer (AJCC) melanoma staging manual, published in 2009 by Ba...
متن کاملHigh-risk surgically resected pediatric melanoma and adjuvant interferon therapy.
BACKGROUND Pediatric patients with high-risk surgically resected melanoma are at risk for relapse, yet little is known about these young patients and how they tolerate high-dose interferon therapy. PROCEDURE We reviewed medical records of patients (< or =18 years) with high-risk melanoma referred to the University of Michigan Pediatric Hematology-Oncology service between January 1989 and July...
متن کاملCryptococcosis in a patient with HIV infection
Background Cryptococcus neoformans is encapsulated yeast with worldwide distribution, which may cause a self-limited pulmonary infection or disseminate (especially to the meninges, but sometimes to the skin, bones, viscera, or other sites). The infection is acquired by inhalation of contaminated soil. Cryptococcosis is a defining opportunistic infection for AIDS; also at increased risk for infe...
متن کاملA suitable data model for HIV infection and epidemic detection
Background: In recent years, there has been an increase in the amount and variety of data generated in the field of healthcare, (e.g., data related to the prevalence of contagious diseases in the society). Various patterns of individuals’ relationships in the society make the analysis of the network a complex, highly important process in detecting and preventing the incidence of diseases....
متن کاملPhase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma.
Twenty-five patients with high-risk resected stages IIB, III, and IV melanoma were immunized with a vaccine consisting of the minimal epitope, immunodominant 9-amino acid peptide derived from the MART-1 tumor antigen (AAGIGILTV) complexed with incomplete Freund's adjuvant. The last three patients received the MART-1(27-35) peptide with incomplete Freund's adjuvant mixed with CRL 1005, a block c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Oncologist
سال: 2010
ISSN: 1083-7159,1549-490X
DOI: 10.1634/theoncologist.2009-0335